HLS Therapeutics Inc (HLS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:HLS Therapeutics Inc (HLS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8150
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
HLS Therapeutics Inc (HLS Therapeutics) is a pharmaceutical company that offers central nervous system and cardiovascular therapeutic products. The company’s product includes clozaril, absorica, vascepa and trinomial. Its clozapine is a pharmaceutical product used in the treatment of schizophrenia. HLS Therapeutics offers novel therapies. The company offers services such as acquisition and commercialization of late-stage development, commercial-stage promoted and established branded pharmaceutical products. The company has its operations in Canada, Barbados and the US. HLS Therapeutics is headquartered in Toronto, Ontario, Canada.

HLS Therapeutics Inc (HLS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HLS Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
HLS Therapeutics Acquires Rights to Clozaril 10
Venture Financing 11
HLS Therapeutics Raises USD30 Million in Venture Financing 11
HLS Therapeutics Raises USD112.8 Million in Venture Financing 12
Partnerships 13
Amarin and HLS Therapeutics Enter into Agreement 13
Merger 14
HLS Therapeutics and Automodular Complete Merger 14
HLS Therapeutics Inc – Key Competitors 16
HLS Therapeutics Inc – Key Employees 17
HLS Therapeutics Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Aug 15, 2018: HLS Therapeutics Announces Q2 2018 Financial Results 19
May 16, 2018: HLS Therapeutics Announces Q1 2018 Financial Results 22
Mar 29, 2018: HLS Therapeutics Reports Fiscal 2017 Financial Results 24
Corporate Communications 26
Mar 16, 2018: HLS Therapeutics Opens Market 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HLS Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HLS Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
HLS Therapeutics Acquires Rights to Clozaril 10
HLS Therapeutics Raises USD30 Million in Venture Financing 11
HLS Therapeutics Raises USD112.8 Million in Venture Financing 12
Amarin and HLS Therapeutics Enter into Agreement 13
HLS Therapeutics and Automodular Complete Merger 14
HLS Therapeutics Inc, Key Competitors 16
HLS Therapeutics Inc, Key Employees 17
HLS Therapeutics Inc, Other Locations 18
HLS Therapeutics Inc, Subsidiaries 18

List of Figures
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
HLS Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[HLS Therapeutics Inc (HLS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • General Motors Company:企業の戦略・SWOT・財務分析
    General Motors Company - Strategy, SWOT and Corporate Finance Report Summary General Motors Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Solvay SA (SOLB)-エネルギー分野:企業M&A・提携分析
    Summary Solvay SA (Solvay) is a chemical manufacturing company, which carries out production of specialty polymers, essential chemicals, silica and rare earth systems, consumer chemicals, polyamide and intermediates, vinyls and acetate tow. Its products include chemical products such as barium stron …
  • Sinclair Broadcast Group, Inc.:企業の戦略・SWOT・財務情報
    Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Nanomix Inc-医療機器分野:企業M&A・提携分析
    Summary Nanomix Inc (Nanomix) is a medical device company that develops portable detection systems for point of care (POC) testing. The company provides Nanomix system, which is an automated system consisting a handheld reader and self-contained assay cartridge with a carbon nanotube biosensor. It p …
  • Outotec Oyj:企業の戦略・SWOT・財務情報
    Outotec Oyj - Strategy, SWOT and Corporate Finance Report Summary Outotec Oyj - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Hitachi Construction Machinery Co., Ltd. (6305):企業の財務・戦略的SWOT分析
    Hitachi Construction Machinery Co., Ltd. (6305) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key st …
  • LCH.Clearnet Group Limited:企業の戦略・SWOT・財務情報
    LCH.Clearnet Group Limited - Strategy, SWOT and Corporate Finance Report Summary LCH.Clearnet Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • ICF International, Inc.:企業の戦略・SWOT・財務情報
    ICF International, Inc. - Strategy, SWOT and Corporate Finance Report Summary ICF International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • DMG America LLC:企業の戦略的SWOT分析
    DMG America LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • San Juan Basin Royalty Trust (SJT):企業の財務・戦略的SWOT分析
    Summary San Juan Basin Royalty Trust (SJT) operates as a trust that has overriding royalty interest divided out of Southland Royalty's oil and gas leasehold and royalty interest in the San Juan Basin of northwestern New Mexico. The trust’s underlying properties include royalty interests, overriding …
  • Tampa Electric Co:企業の戦略的SWOT分析
    Tampa Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Old National Bancorp:企業のM&A・事業提携・投資動向
    Old National Bancorp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Old National Bancorp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Midmark Corp-医療機器分野:企業M&A・提携分析
    Summary Midmark Corp (Midmark) is a medical device company that manufactures and markets medical, dental and veterinary healthcare equipments. The company offers medical products such as power procedures tables and chairs, power examination tables, manual examination tables, lighting products, and i …
  • Clinigen Group Plc (CLIN):企業の財務・戦略的SWOT分析
    Summary Clinigen Group Plc (Clinigen Group) operates as a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibati …
  • Admedus Ltd (AHZ):企業の財務・戦略的SWOT分析
    Admedus Ltd (AHZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Ak Bars Bank:企業の戦略・SWOT・財務分析
    Ak Bars Bank - Strategy, SWOT and Corporate Finance Report Summary Ak Bars Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • CAS Medical Systems Inc (CASM):企業の財務・戦略的SWOT分析
    Summary CAS Medical Systems Inc (CASMED) is a medical device company that designs, manufactures and markets technologies and monitors. The company offers technologies and monitors that deliver patient data. Its products comprise FORE-SIGHT absolute tissue oximeter, blood pressure measurement technol …
  • Verbundnetz Gas Aktiengesellschaft:石油・ガス:M&Aディール及び事業提携情報
    Summary Verbundnetz Gas AG (VNG), a subsidiary of EnBW Energie Baden-Wurttemberg AG, is a natural gas company that explores, produces, stores, trades and transports natural gas. The company has natural gas licenses on the Norwegian continental shelf and the Danish North Sea. VNG also offers gas stor …
  • Exelon Corporation:発電所・企業SWOT分析
    Exelon Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • iDD biotech SAS-製薬・医療分野:企業M&A・提携分析
    Summary iDD biotech SAS (iDD biotech) is a healthcare products provider that discovers and develops differentiated therapeutic antibodies. The company's products comprise pre-clinical stage therapeutic monoclonal antibodies and active drug discovery programs. It develops therapies for the treatment …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆